Extended survival in stage IV adrenocortical carcinoma with recurrence and bone metastases

View at publisher Summarise with VIRAT
Authors: Joseph T Lehmann, Patrick Klang, Assef Jawaada, Gabriele Galata, Klaus‐Martin Schulte
Cited by: 0
References: 15

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Adrenocortical carcinomas (ACCs) are rare aggressive endocrine tumours that commonly spread to the lymph nodes, liver and lung. Infrequently they metastasise to the bone and when present are often fatal.We report the case of a middle-aged male with a 23 cm ACC with extensive liver metastases at presentation. Index management was a two-stage procedure with resection of the primary lesion en bloc followed by hepatectomy with radiofrequency ablation to inoperable metastases. He had recurrence of disease with a left femur metastasis and additional liver metastases. Remission was obtained with radiotherapy, chemotherapy, bone resorptive inhibitors, mitotane and repeat radiofrequency ablation. He was discharged from regular surveillance and remains alive and free of active disease 14 years after initial diagnosis. To our knowledge, this is the longest recorded survival of a patient with stage IV ACC with recurrent disease and bone metastases.

Fields of Study & Subjects

Adrenal and Paraganglionic Tumors Neuroendocrine Tumor Research Advances Pituitary Gland Disorders and Treatments

Publication details

Journal / source
BMJ Case Reports
Volume
19
Issue
3
Pages
e268362–e268362
Publication date
1 March 2026
Language
EN